Browsing by Author "Cinel, Güzin"
Now showing items 1-4 of 4
-
Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis
Şişmanlar Eyüboğlu, Tuğba; Doğru, Deniz; Çakır, Erkan; Çobanoğlu, Nazan; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Şen, Velat; Şen, Hadice Selimoğlu (Wiley, 2020)Background Pseudo-Bartter syndrome (PBS) is a rare complication of cystic fibrosis (CF) and there are limited data in the literature about it. We aimed to compare clinical features and accompanying findings of patients ... -
Cystic fibrosis in Turkey: First data from the national registry
Doğru, Deniz; Çakır, Erkan; Şişmanlar, Tuğba; Çobanoğlu, Nazan; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Şen, Velat; Şen, Hadice S. (Wiley, 2020)Background Cystic fibrosis (CF) care has been implemented in Turkey for a long time; however, there had been no patient registry. For this purpose, the Turkish National CF Registry was established. We present the first ... -
Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Çobanoğlu, Nazan; Özçelik, Uğur; Çakır, Erkan; Eyüboğlu, Tuğba Şişmanlar; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Şen, Velat; Şen, Hadice Selimoğlu (Wiley, 2020)Background A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, and elexacafto ... -
Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
Uytun, Salih; Cinel, Güzin; Polat, Sanem Eryılmaz; Tabakçı, Satı Özkan; Kiper, Nural; Yalçın, Ebru; Şen, Velat; Şen, Hadice Selimoğlu (John Wiley and Sons Inc, 2023)Background: Cystic fibrosis (CF) is an autosomal recessive disorder caused by CF transmembrane conductance regulator (CFTR) genetic variants. CFTR modulators improve pulmonary function and reduce respiratory infections in ...
